248 related articles for article (PubMed ID: 28481851)
1. What To Do With Lateral Nodal Disease in Low Locally Advanced Rectal Cancer? A Call for Further Reflection and Research.
Kusters M; Slater A; Muirhead R; Hompes R; Guy RJ; Jones OM; George BD; Lindsey I; Mortensen NJ; Cunningham C
Dis Colon Rectum; 2017 Jun; 60(6):577-585. PubMed ID: 28481851
[TBL] [Abstract][Full Text] [Related]
2. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.
Ogura A; Konishi T; Beets GL; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Rutten HJT; Tuynman JB; Kusters M;
JAMA Surg; 2019 Sep; 154(9):e192172. PubMed ID: 31268504
[TBL] [Abstract][Full Text] [Related]
3. Prediction of N0 Irradiated Rectal Cancer Comparing MRI Before and After Preoperative Chemoradiotherapy.
Pomerri F; Crimì F; Veronese N; Perin A; Lacognata C; Bergamo F; Boso C; Maretto I
Dis Colon Rectum; 2017 Nov; 60(11):1184-1191. PubMed ID: 28991083
[TBL] [Abstract][Full Text] [Related]
4. Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters.
Baucom RB; Maguire LH; Kavalukas SL; Geiger TM; Ford MM; Muldoon RL; Hopkins MB; Hawkins AT
Dis Colon Rectum; 2017 Dec; 60(12):1260-1266. PubMed ID: 29112561
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of MRI-detected lateral nodal disease and extramural vascular invasion in rectal cancer.
Schaap DP; Ogura A; Nederend J; Maas M; Cnossen JS; Creemers GJ; van Lijnschoten I; Nieuwenhuijzen GAP; Rutten HJT; Kusters M
Br J Surg; 2018 Dec; 105(13):1844-1852. PubMed ID: 30079958
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic Versus Open Lateral Lymph Node Dissection for Locally Advanced Low Rectal Cancer: A Subgroup Analysis of a Large Multicenter Cohort Study in Japan.
Yamaguchi T; Konishi T; Kinugasa Y; Yamamoto S; Akiyoshi T; Okamura R; Ito M; Nishimura Y; Shiozawa M; Yamaguchi S; Hida K; Sakai Y; Watanabe M
Dis Colon Rectum; 2017 Sep; 60(9):954-964. PubMed ID: 28796734
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer.
Ogura A; Konishi T; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Beets GL; Rutten HJT; Kusters M;
J Clin Oncol; 2019 Jan; 37(1):33-43. PubMed ID: 30403572
[TBL] [Abstract][Full Text] [Related]
8. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?
Hughes R; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Livingstone JI; McDonald PJ; Meyrick Thomas J; Mitchell IC; Northover JM; Phillips R; Wallace M; Windsor A; Novell JR
Int J Colorectal Dis; 2006 Jan; 21(1):11-7. PubMed ID: 15864605
[TBL] [Abstract][Full Text] [Related]
9. Clinical Implications of Pretreatment: Lymphocyte-to-Monocyte Ratio in Patients With Rectal Cancer Receiving Preoperative Chemoradiotherapy.
Yamamoto A; Toiyama Y; Okugawa Y; Oki S; Ide S; Saigusa S; Araki T; Kusunoki M
Dis Colon Rectum; 2019 Feb; 62(2):171-180. PubMed ID: 30451750
[TBL] [Abstract][Full Text] [Related]
10. Oncological Outcomes of Patients with Locally Advanced Rectal Cancer and Lateral Pelvic Lymph Node Involvement.
Sapci I; Delaney CP; Liska D; Amarnath S; Kalady MF; Steele SR; Gorgun E
J Gastrointest Surg; 2019 Jul; 23(7):1454-1460. PubMed ID: 31012043
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Different Nodal Staging in Patients With Locally Advanced Mid-low Rectal Cancer After Long-term Neoadjuvant Chemoradiation Therapy.
Petrucciani N; Carra MC; Martínez-Pérez A; Vitali GC; Landi F; Genova P; Memeo R; Brunetti F; Espin E; Ris F; De'angelis N;
Anticancer Res; 2019 Apr; 39(4):2113-2120. PubMed ID: 30952757
[TBL] [Abstract][Full Text] [Related]
12. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
[TBL] [Abstract][Full Text] [Related]
13. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC
Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088
[TBL] [Abstract][Full Text] [Related]
14. Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer.
Park JS; Park SY; Kim HJ; Cho SH; Kwak SG; Choi GS
Dis Colon Rectum; 2019 Apr; 62(4):408-416. PubMed ID: 30688680
[TBL] [Abstract][Full Text] [Related]
15. Postoperative Chemoradiotherapy After Local Resection for High-Risk T1 to T2 Low Rectal Cancer: Results of a Single-Arm, Multi-Institutional, Phase II Clinical Trial.
Sasaki T; Ito Y; Ohue M; Kanemitsu Y; Kobatake T; Ito M; Moriya Y; Saito N
Dis Colon Rectum; 2017 Sep; 60(9):914-921. PubMed ID: 28796729
[TBL] [Abstract][Full Text] [Related]
16. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial.
Wei M; Wu Q; Fan C; Li Y; Chen X; Zhou Z; Han J; Wang Z
Trials; 2016 Nov; 17(1):561. PubMed ID: 27884204
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision].
Zhang JX; Yang Z; Fan P; Zhang JJ; Xin L; Hou LN; Du XS; Yang XT
Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):121-126. PubMed ID: 29502372
[No Abstract] [Full Text] [Related]
18. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
[TBL] [Abstract][Full Text] [Related]
19. Oncological Outcomes of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer Treated With Preoperative Chemoradiotherapy.
Ishihara S; Kawai K; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
Dis Colon Rectum; 2017 May; 60(5):469-476. PubMed ID: 28383446
[TBL] [Abstract][Full Text] [Related]
20. Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter?
Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Coelho AQ; Figueiredo MN; Fernandez LM; Gama-Rodrigues J
Dis Colon Rectum; 2014 Nov; 57(11):1253-9. PubMed ID: 25285691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
